Product Information

CHLORDIAZEPOXIDE-CLIDINIUM CAP is a generic product labeled by American Health Packaging, priced at $0.2545 per EA under NDC 60687063994. Its NADAC has been published 217 times since Jun 29, 2022.

FDA first approved this application on Apr 26, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CHLORDIAZEPOXIDE-CLIDINIUM CAP

Chlordiazepoxide Hydrochloride and Clidinium Bromide
$0.2545per EA
DEA Schedule CIV

Strength

5; 2.5 mg/1; mg/1

NDC

60687063994

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA214065

FDA Approved

4/26/2021

TE Code

AB

On Market Since

1/6/2022

Pharmacological Classes

Anticholinergic
Benzodiazepine
Benzodiazepines
Cholinergic Antagonists
Decreased Parasympathetic Acetylcholine Activity
Digestive/GI System Activity Alteration
GI Motility Alteration

Price Statistics

The NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has been published 217 times since Jun 29, 2022, and over the history we have for it it has declined 73.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2545 per EA
All-time high$0.9581 (Jul 13, 2022)
All-time low$0.2088 (Apr 19, 2023)
52-week high$0.3051
52-week low$0.2405
Median price$0.3148
Average price$0.3423
Largest weekly change+88.8% (May 17, 2023)
Weeks tracked217
Tracking sinceJun 29, 2022

Price History

1W

-2.5%

1M

-2.5%

3M

-6.3%

6M

+3.2%

1Y

-11.0%

3Y

-31.0%

5Y

N/A

All

-73.4%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CHLORDIAZEPOXIDE-CLIDINIUM CAP?

The current National Average Drug Acquisition Cost (NADAC) for CHLORDIAZEPOXIDE-CLIDINIUM CAP, manufactured by American Health Packaging, is $0.2545 per EA (NDC 60687063994), effective Aug 19, 2026.

How has the price of CHLORDIAZEPOXIDE-CLIDINIUM CAP changed over time?

Over the history we have for it, the NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has declined 73.4%. It has been tracked across 217 weekly CMS publications since Jun 29, 2022.

What are the highest and lowest recorded NADAC prices for CHLORDIAZEPOXIDE-CLIDINIUM CAP?

Since Jun 29, 2022, the NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has ranged from a low of $0.2088 (Apr 19, 2023) to a high of $0.9581 (Jul 13, 2022), with a median of $0.3148 per EA.

Are there cheaper alternatives to CHLORDIAZEPOXIDE-CLIDINIUM CAP?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CHLORDIAZEPOXIDE-CLIDINIUM CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures CHLORDIAZEPOXIDE-CLIDINIUM CAP?

CHLORDIAZEPOXIDE-CLIDINIUM CAP (NDC 60687063994) is labeled by American Health Packaging, and CMS classifies it as a generic product.